{
    "Trade/Device Name(s)": [
        "Verigene\u00ae Respiratory Virus Nucleic Acid Test on the Verigene\u00ae SP System (RVNATsp)",
        "Verigene\u00ae SP System"
    ],
    "Submitter Information": "Nanosphere, Inc.",
    "510(k) Number": "K092566",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083088"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "NSU"
    ],
    "Summary Letter Date": "September 29, 2009",
    "Summary Letter Received Date": "September 30, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A Virus",
        "Influenza B Virus",
        "Respiratory Syncytial Virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Universal Transport Media (Copan)"
    ],
    "Instrument(s)/Platform(s)": [
        "Verigene\u00ae SP System",
        "Verigene SP Processor",
        "Verigene Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Magnetic bead-based viral RNA extraction",
        "Multiplex RT-PCR",
        "Gold nanoparticle probe-based detection"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid amplification",
        "Probe-based hybridization detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System",
        "Kit",
        "Analyzer",
        "Platform",
        "Cartridge",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Verigene Respiratory Virus Nucleic Acid Test multiplex assay for Influenza A/B and RSV on the automated Verigene SP System.",
    "Indications for Use Summary": "Qualitative multiplex in vitro diagnostic test to detect and identify Influenza A, Influenza B, and RSV nucleic acids from nasopharyngeal swabs in symptomatic patients as an aid in differential diagnosis; not for detection of Influenza C.",
    "fda_folder": "Microbiology"
}